Cargando…

IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis

The hallmarks of inflammatory bowel disease are mucosal damage and ulceration, which are known to be high-risk conditions for the development of colorectal cancer. Recently, interleukin (IL)-33 and its receptor ST2 have emerged as critical modulators in inflammatory disorders. Even though several st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo Thi Phuong, Nhi, Palmieri, Vittoria, Adamczyk, Alexandra, Klopfleisch, Robert, Langhorst, Jost, Hansen, Wiebke, Westendorf, Astrid M., Pastille, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320374/ https://www.ncbi.nlm.nih.gov/pubmed/34335571 http://dx.doi.org/10.3389/fimmu.2021.669787

Ejemplares similares

Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity
por: Palmieri, Vittoria, et al.
Publicado: (2021)

Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer
por: Pastille, Eva, et al.
Publicado: (2021)

The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
por: Pastille, Eva, et al.
Publicado: (2019)

Distinct Kinetics in the Frequency of Peripheral CD4(+) T Cells in Patients with Ulcerative Colitis Experiencing a Flare during Treatment with Mesalazine or with a Herbal Preparation of Myrrh, Chamomile, and Coffee Charcoal
por: Langhorst, Jost, et al.
Publicado: (2014)

Depletion of Foxp3(+) regulatory T cells is accompanied by an increase in the relative abundance of Firmicutes in the murine gut microbiome
por: Kehrmann, Jan, et al.
Publicado: (2019)

Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer
por: Pastille, Eva, et al.
Publicado: (2017)

IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis
por: Miller, Jessica E., et al.
Publicado: (2021)

Targeting Antigens to Dec-205 on Dendritic Cells Induces Immune Protection in Experimental Colitis in Mice
por: Wadwa, Munisch, et al.
Publicado: (2016)

Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells
por: Creyns, Brecht, et al.
Publicado: (2020)

Local Induction of Immunosuppressive CD8(+) T Cells in the Gut-Associated Lymphoid Tissues
por: Fleissner, Diana, et al.
Publicado: (2010)

Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis
por: Meiners, Jana, et al.
Publicado: (2019)

Serum free culture for the expansion and study of type 2 innate lymphoid cells
por: de Lucía Finkel, Pablo, et al.
Publicado: (2021)

IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii
por: Clark, Joseph T, et al.
Publicado: (2021)

IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing
por: Rak, Gregory D, et al.
Publicado: (2016)

IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow
por: Stier, Matthew T., et al.
Publicado: (2018)

Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis
por: Chen, Wei-Yu, et al.
Publicado: (2021)

Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma
por: Sun, Fengfei, et al.
Publicado: (2023)

Glucocorticoid induced group 2 innate lymphoid cell overactivation exacerbates experimental colitis
por: Feng, Bingcheng, et al.
Publicado: (2022)

Innate Lymphoid Cells in the Skin
por: Kim, Brian S.
Publicado: (2014)

Innate lymphoid cells and the skin
por: Salimi, Maryam, et al.
Publicado: (2014)

IL-33 induces innate lymphoid cell–mediated airway inflammation by activating mammalian target of rapamycin
por: Salmond, Robert J., et al.
Publicado: (2012)

Soluble ST2 suppresses the effect of interleukin-33 on lung type 2 innate lymphoid cells
por: Hayakawa, Hiroko, et al.
Publicado: (2016)

Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy
por: Park, Chan Hyuk, et al.
Publicado: (2020)

A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
por: Salimi, Maryam, et al.
Publicado: (2013)

IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
por: Frisbee, Alyse L., et al.
Publicado: (2019)

Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury
por: Chen, Wei-Yu, et al.
Publicado: (2020)

Epigenomic Views of Innate Lymphoid Cells
por: Sciumè, Giuseppe, et al.
Publicado: (2017)

Innate Lymphoid Cells in Intestinal Inflammation
por: Geremia, Alessandra, et al.
Publicado: (2017)

Shaping Innate Lymphoid Cell Diversity
por: Huang, Qiutong, et al.
Publicado: (2017)

Immunoregulatory functions of innate lymphoid cells
por: Crome, Sarah Q., et al.
Publicado: (2018)

Physiological Regulation of Innate Lymphoid Cells
por: Jacquelot, Nicolas, et al.
Publicado: (2019)

Innate Lymphoid Cells in Mucosal Immunity
por: Panda, Santosh K., et al.
Publicado: (2019)

Plastic fantastic innate lymphoid cells
por: Lanier, Lewis L.
Publicado: (2019)

Neuroendocrine regulation of innate lymphoid cells
por: Quatrini, Linda, et al.
Publicado: (2018)

Innate Lymphoid Cells in Tumor Immunity
por: van Beek, Jasper J. P., et al.
Publicado: (2016)

HiJAKing Innate Lymphoid Cells?
por: Sciumè, Giuseppe, et al.
Publicado: (2017)

Immune checkpoints on innate lymphoid cells
por: Chiossone, Laura, et al.
Publicado: (2017)

Innate Lymphoid Cells in Renal Inflammation
por: Becker, Martina, et al.
Publicado: (2020)

Innate lymphoid cells in inflammatory arthritis
por: Fang, Weiting, et al.
Publicado: (2020)

Innate Lymphoid Cells in Human Pregnancy
por: Mendes, João, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3kfqjdh7ogl50cjjkge7pfdf4o